SCHEMBL29566874

SCHEMBL29566874

Cc1ccccc1-c1nc(NS(=O)(=O)c2cnn(C)c2)nc(-c2ccccc2C)c1C(F)(F)C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 3/20 0.39
▸ HTR7 P34969 3/20 0.39
▸ PTGS2 P35354 2/20 0.37
▸ PTGS1 P23219 1/20 0.37
▸ RXFP1 Q9HBX9 2/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CCNE1 P24864 2/20 0.36
▸ CDK2 P24941 2/20 0.36
▸ BRAF P15056 1/20 0.36
▸ CCNE2 O96020 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ PIK3CG P48736 2/20 0.35
▸ PIK3CD O00329 1/20 0.35
▸ PIK3CB P42338 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ SCN9A Q15858 1/20 0.35
▸ PCK1 P35558 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ EGFR P00533 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29567155 0.94 HTR1A (0.35) HTR1AHTR7PTGS2PTGS1RXFP1
SCHEMBL24309502 0.94 HTR1A (0.35) HTR1AHTR7PTGS2PTGS1RXFP1
SCHEMBL24310083 0.91 HTR1A (0.39) HTR1AHTR7PTGS2PTGS1RXFP1
SCHEMBL24309608 0.87 HTR1A (0.36) HTR1AHTR7PTGS2PTGS1RXFP1
SCHEMBL24309547 0.85 HTR1A (0.37) HTR1AHTR7RXFP1KMT2ACCNE1
SCHEMBL29566455 0.85 HTR1A (0.37) HTR1AHTR7RXFP1KMT2ACCNE1
SCHEMBL24310673 0.85 HTR1A (0.40) HTR1AHTR7PTGS2PTGS1RXFP1
SCHEMBL24309875 0.84 HTR1A (0.39) HTR1AHTR7RXFP1KMT2ACCNE1
SCHEMBL29566963 0.84 RAD52 (0.36) HTR1AHTR7BRD4KDM4E
SCHEMBL24309497 0.84 HTR1A (0.40) HTR1AHTR7PTGS2PTGS1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback